HEADER CHAPERONE 15-MAY-18 6DFM TITLE CRYSTAL STRUCTURE OF HUMAN GRP78 IN COMPLEX WITH 8-AMINOADENOSINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIC RETICULUM CHAPERONE BIP; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 26-407; COMPND 5 SYNONYM: 78 KDA GLUCOSE-REGULATED PROTEIN, GRP-78, BINDING- COMPND 6 IMMUNOGLOBULIN PROTEIN, BIP, HEAT SHOCK PROTEIN 70 FAMILY PROTEIN 5, COMPND 7 HSP70 FAMILY PROTEIN 5, HEAT SHOCK PROTEIN FAMILY A MEMBER 5, COMPND 8 IMMUNOGLOBULIN HEAVY CHAIN-BINDING PROTEIN; COMPND 9 EC: 3.6.4.10; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSPA5, GRP78; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28-MHL KEYWDS ENDOPLASMIC RETICULUM, UNFOLDED PROTEIN RESPONSE, NUCLEOSIDE ANALOG, KEYWDS 2 CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR R.P.FERRIE,Y.CHEN,T.ANTOSHCHENKO,O.M.COONEY,Y.HUANG,H.W.PARK REVDAT 2 13-MAR-24 6DFM 1 REMARK REVDAT 1 15-MAY-19 6DFM 0 JRNL AUTH R.P.FERRIE,Y.CHEN,T.ANTOSHCHENKO,O.M.COONEY,Y.HUANG,H.W.PARK JRNL TITL CRYSTAL STRUCTURE OF HUMAN GRP78 IN COMPLEX WITH JRNL TITL 2 8-AMINOADENOSINE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 39640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 1922 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2561 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2320 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2421 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.47 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5930 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.08 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -15.23580 REMARK 3 B22 (A**2) : 4.66030 REMARK 3 B33 (A**2) : 10.57550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.98180 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.275 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.198 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.269 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.199 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6064 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8186 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2180 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 178 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 866 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6064 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 808 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7561 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.90 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DFM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1000234504. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03327 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS INTEL64_LINUX_X86_64 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39667 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 88.263 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10000 REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.63900 REMARK 200 R SYM FOR SHELL (I) : 0.63900 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: PLATES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRICLINIC CRYSTALS OF APO GRP78 WERE REMARK 280 OBSERVED IN 0.1 M TRIS-HCL, 25% PEG3350, 0.1 M SODIUM/POTASSIUM REMARK 280 TARTRATE. INITIAL CRYSTALS WERE THEN MICROSEEDED IN 25% PEG3350, REMARK 280 0.1 M TRIS-HCL, 0.2 M SODIUM CHLORIDE. THESE NEW APO MONOCLINIC REMARK 280 CRYSTALS WERE SOAKED WITH 5 MM 8-AMINOADENOSINE FOR ONE WEEK., REMARK 280 PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.38750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 83 -15.73 -145.16 REMARK 500 THR A 124 -2.36 71.96 REMARK 500 LYS A 213 33.30 -85.34 REMARK 500 PHE A 379 35.26 -93.73 REMARK 500 ASN A 380 51.34 39.13 REMARK 500 THR B 124 -2.91 73.13 REMARK 500 PHE B 379 35.40 -93.81 REMARK 500 ASN B 380 51.42 38.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3BH A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3BH B 501 DBREF 6DFM A 26 407 UNP P11021 BIP_HUMAN 26 407 DBREF 6DFM B 26 407 UNP P11021 BIP_HUMAN 26 407 SEQRES 1 A 382 ASP VAL GLY THR VAL VAL GLY ILE ASP LEU GLY THR THR SEQRES 2 A 382 TYR SER CYS VAL GLY VAL PHE LYS ASN GLY ARG VAL GLU SEQRES 3 A 382 ILE ILE ALA ASN ASP GLN GLY ASN ARG ILE THR PRO SER SEQRES 4 A 382 TYR VAL ALA PHE THR PRO GLU GLY GLU ARG LEU ILE GLY SEQRES 5 A 382 ASP ALA ALA LYS ASN GLN LEU THR SER ASN PRO GLU ASN SEQRES 6 A 382 THR VAL PHE ASP ALA LYS ARG LEU ILE GLY ARG THR TRP SEQRES 7 A 382 ASN ASP PRO SER VAL GLN GLN ASP ILE LYS PHE LEU PRO SEQRES 8 A 382 PHE LYS VAL VAL GLU LYS LYS THR LYS PRO TYR ILE GLN SEQRES 9 A 382 VAL ASP ILE GLY GLY GLY GLN THR LYS THR PHE ALA PRO SEQRES 10 A 382 GLU GLU ILE SER ALA MET VAL LEU THR LYS MET LYS GLU SEQRES 11 A 382 THR ALA GLU ALA TYR LEU GLY LYS LYS VAL THR HIS ALA SEQRES 12 A 382 VAL VAL THR VAL PRO ALA TYR PHE ASN ASP ALA GLN ARG SEQRES 13 A 382 GLN ALA THR LYS ASP ALA GLY THR ILE ALA GLY LEU ASN SEQRES 14 A 382 VAL MET ARG ILE ILE ASN GLU PRO THR ALA ALA ALA ILE SEQRES 15 A 382 ALA TYR GLY LEU ASP LYS ARG GLU GLY GLU LYS ASN ILE SEQRES 16 A 382 LEU VAL PHE ASP LEU GLY GLY GLY THR PHE ASP VAL SER SEQRES 17 A 382 LEU LEU THR ILE ASP ASN GLY VAL PHE GLU VAL VAL ALA SEQRES 18 A 382 THR ASN GLY ASP THR HIS LEU GLY GLY GLU ASP PHE ASP SEQRES 19 A 382 GLN ARG VAL MET GLU HIS PHE ILE LYS LEU TYR LYS LYS SEQRES 20 A 382 LYS THR GLY LYS ASP VAL ARG LYS ASP ASN ARG ALA VAL SEQRES 21 A 382 GLN LYS LEU ARG ARG GLU VAL GLU LYS ALA LYS ARG ALA SEQRES 22 A 382 LEU SER SER GLN HIS GLN ALA ARG ILE GLU ILE GLU SER SEQRES 23 A 382 PHE TYR GLU GLY GLU ASP PHE SER GLU THR LEU THR ARG SEQRES 24 A 382 ALA LYS PHE GLU GLU LEU ASN MET ASP LEU PHE ARG SER SEQRES 25 A 382 THR MET LYS PRO VAL GLN LYS VAL LEU GLU ASP SER ASP SEQRES 26 A 382 LEU LYS LYS SER ASP ILE ASP GLU ILE VAL LEU VAL GLY SEQRES 27 A 382 GLY SER THR ARG ILE PRO LYS ILE GLN GLN LEU VAL LYS SEQRES 28 A 382 GLU PHE PHE ASN GLY LYS GLU PRO SER ARG GLY ILE ASN SEQRES 29 A 382 PRO ASP GLU ALA VAL ALA TYR GLY ALA ALA VAL GLN ALA SEQRES 30 A 382 GLY VAL LEU SER GLY SEQRES 1 B 382 ASP VAL GLY THR VAL VAL GLY ILE ASP LEU GLY THR THR SEQRES 2 B 382 TYR SER CYS VAL GLY VAL PHE LYS ASN GLY ARG VAL GLU SEQRES 3 B 382 ILE ILE ALA ASN ASP GLN GLY ASN ARG ILE THR PRO SER SEQRES 4 B 382 TYR VAL ALA PHE THR PRO GLU GLY GLU ARG LEU ILE GLY SEQRES 5 B 382 ASP ALA ALA LYS ASN GLN LEU THR SER ASN PRO GLU ASN SEQRES 6 B 382 THR VAL PHE ASP ALA LYS ARG LEU ILE GLY ARG THR TRP SEQRES 7 B 382 ASN ASP PRO SER VAL GLN GLN ASP ILE LYS PHE LEU PRO SEQRES 8 B 382 PHE LYS VAL VAL GLU LYS LYS THR LYS PRO TYR ILE GLN SEQRES 9 B 382 VAL ASP ILE GLY GLY GLY GLN THR LYS THR PHE ALA PRO SEQRES 10 B 382 GLU GLU ILE SER ALA MET VAL LEU THR LYS MET LYS GLU SEQRES 11 B 382 THR ALA GLU ALA TYR LEU GLY LYS LYS VAL THR HIS ALA SEQRES 12 B 382 VAL VAL THR VAL PRO ALA TYR PHE ASN ASP ALA GLN ARG SEQRES 13 B 382 GLN ALA THR LYS ASP ALA GLY THR ILE ALA GLY LEU ASN SEQRES 14 B 382 VAL MET ARG ILE ILE ASN GLU PRO THR ALA ALA ALA ILE SEQRES 15 B 382 ALA TYR GLY LEU ASP LYS ARG GLU GLY GLU LYS ASN ILE SEQRES 16 B 382 LEU VAL PHE ASP LEU GLY GLY GLY THR PHE ASP VAL SER SEQRES 17 B 382 LEU LEU THR ILE ASP ASN GLY VAL PHE GLU VAL VAL ALA SEQRES 18 B 382 THR ASN GLY ASP THR HIS LEU GLY GLY GLU ASP PHE ASP SEQRES 19 B 382 GLN ARG VAL MET GLU HIS PHE ILE LYS LEU TYR LYS LYS SEQRES 20 B 382 LYS THR GLY LYS ASP VAL ARG LYS ASP ASN ARG ALA VAL SEQRES 21 B 382 GLN LYS LEU ARG ARG GLU VAL GLU LYS ALA LYS ARG ALA SEQRES 22 B 382 LEU SER SER GLN HIS GLN ALA ARG ILE GLU ILE GLU SER SEQRES 23 B 382 PHE TYR GLU GLY GLU ASP PHE SER GLU THR LEU THR ARG SEQRES 24 B 382 ALA LYS PHE GLU GLU LEU ASN MET ASP LEU PHE ARG SER SEQRES 25 B 382 THR MET LYS PRO VAL GLN LYS VAL LEU GLU ASP SER ASP SEQRES 26 B 382 LEU LYS LYS SER ASP ILE ASP GLU ILE VAL LEU VAL GLY SEQRES 27 B 382 GLY SER THR ARG ILE PRO LYS ILE GLN GLN LEU VAL LYS SEQRES 28 B 382 GLU PHE PHE ASN GLY LYS GLU PRO SER ARG GLY ILE ASN SEQRES 29 B 382 PRO ASP GLU ALA VAL ALA TYR GLY ALA ALA VAL GLN ALA SEQRES 30 B 382 GLY VAL LEU SER GLY HET 3BH A 501 20 HET 3BH B 501 20 HETNAM 3BH (2R,3R,4S,5R)-2-(6,8-DIAMINOPURIN-9-YL)-5- HETNAM 2 3BH (HYDROXYMETHYL)OXOLANE-3,4-DIOL HETSYN 3BH 8-AMINOADENOSINE FORMUL 3 3BH 2(C10 H14 N6 O4) FORMUL 5 HOH *440(H2 O) HELIX 1 AA1 GLY A 77 ASN A 82 1 6 HELIX 2 AA2 ASP A 94 LEU A 98 5 5 HELIX 3 AA3 ASP A 105 ILE A 112 1 8 HELIX 4 AA4 LYS A 113 LEU A 115 5 3 HELIX 5 AA5 ALA A 141 GLY A 162 1 22 HELIX 6 AA6 ASN A 177 ALA A 191 1 15 HELIX 7 AA7 GLU A 201 TYR A 209 1 9 HELIX 8 AA8 GLY A 210 ARG A 214 5 5 HELIX 9 AA9 GLY A 254 GLY A 275 1 22 HELIX 10 AB1 ASP A 277 LYS A 280 5 4 HELIX 11 AB2 ASP A 281 LEU A 299 1 19 HELIX 12 AB3 ARG A 324 THR A 338 1 15 HELIX 13 AB4 THR A 338 SER A 349 1 12 HELIX 14 AB5 LYS A 352 ILE A 356 5 5 HELIX 15 AB6 GLY A 363 ARG A 367 5 5 HELIX 16 AB7 ILE A 368 PHE A 379 1 12 HELIX 17 AB8 GLU A 392 GLY A 407 1 16 HELIX 18 AB9 GLY B 77 GLN B 83 1 7 HELIX 19 AC1 ASN B 87 THR B 91 5 5 HELIX 20 AC2 ASP B 94 LEU B 98 5 5 HELIX 21 AC3 ASP B 105 ILE B 112 1 8 HELIX 22 AC4 LYS B 113 LEU B 115 5 3 HELIX 23 AC5 ALA B 141 GLY B 162 1 22 HELIX 24 AC6 ASN B 177 ALA B 191 1 15 HELIX 25 AC7 GLU B 201 TYR B 209 1 9 HELIX 26 AC8 GLY B 210 ARG B 214 5 5 HELIX 27 AC9 GLY B 254 GLY B 275 1 22 HELIX 28 AD1 ASP B 277 LYS B 280 5 4 HELIX 29 AD2 ASP B 281 LEU B 299 1 19 HELIX 30 AD3 ARG B 324 THR B 338 1 15 HELIX 31 AD4 THR B 338 SER B 349 1 12 HELIX 32 AD5 LYS B 352 ILE B 356 5 5 HELIX 33 AD6 GLY B 363 ARG B 367 5 5 HELIX 34 AD7 ILE B 368 PHE B 379 1 12 HELIX 35 AD8 GLU B 392 GLY B 407 1 16 SHEET 1 AA1 3 ARG A 49 ILE A 52 0 SHEET 2 AA1 3 TYR A 39 LYS A 46 -1 N VAL A 44 O GLU A 51 SHEET 3 AA1 3 THR A 62 PRO A 63 -1 O THR A 62 N SER A 40 SHEET 1 AA2 5 ARG A 49 ILE A 52 0 SHEET 2 AA2 5 TYR A 39 LYS A 46 -1 N VAL A 44 O GLU A 51 SHEET 3 AA2 5 VAL A 31 LEU A 35 -1 N GLY A 32 O GLY A 43 SHEET 4 AA2 5 HIS A 167 VAL A 172 1 O VAL A 169 N ILE A 33 SHEET 5 AA2 5 ASN A 194 ASN A 200 1 O ASN A 194 N ALA A 168 SHEET 1 AA3 3 ARG A 74 ILE A 76 0 SHEET 2 AA3 3 VAL A 66 PHE A 68 -1 N ALA A 67 O LEU A 75 SHEET 3 AA3 3 THR A 91 VAL A 92 -1 O VAL A 92 N VAL A 66 SHEET 1 AA4 3 LYS A 118 LYS A 122 0 SHEET 2 AA4 3 LYS A 125 ASP A 131 -1 O TYR A 127 N VAL A 120 SHEET 3 AA4 3 THR A 137 PHE A 140 -1 O PHE A 140 N ILE A 128 SHEET 1 AA5 4 VAL A 241 ASP A 250 0 SHEET 2 AA5 4 PHE A 230 ASP A 238 -1 N LEU A 234 O ALA A 246 SHEET 3 AA5 4 GLU A 217 LEU A 225 -1 N ILE A 220 O LEU A 235 SHEET 4 AA5 4 GLU A 358 VAL A 362 1 O VAL A 360 N PHE A 223 SHEET 1 AA6 2 GLN A 304 TYR A 313 0 SHEET 2 AA6 2 GLU A 316 THR A 323 -1 O GLU A 320 N ILE A 307 SHEET 1 AA7 3 ARG B 49 ILE B 52 0 SHEET 2 AA7 3 TYR B 39 LYS B 46 -1 N VAL B 44 O GLU B 51 SHEET 3 AA7 3 THR B 62 PRO B 63 -1 O THR B 62 N SER B 40 SHEET 1 AA8 5 ARG B 49 ILE B 52 0 SHEET 2 AA8 5 TYR B 39 LYS B 46 -1 N VAL B 44 O GLU B 51 SHEET 3 AA8 5 VAL B 31 LEU B 35 -1 N GLY B 32 O GLY B 43 SHEET 4 AA8 5 HIS B 167 VAL B 172 1 O VAL B 169 N ILE B 33 SHEET 5 AA8 5 ASN B 194 ASN B 200 1 O ASN B 194 N ALA B 168 SHEET 1 AA9 2 VAL B 66 PHE B 68 0 SHEET 2 AA9 2 ARG B 74 ILE B 76 -1 O LEU B 75 N ALA B 67 SHEET 1 AB1 3 LYS B 118 LYS B 122 0 SHEET 2 AB1 3 LYS B 125 ASP B 131 -1 O TYR B 127 N VAL B 120 SHEET 3 AB1 3 THR B 137 PHE B 140 -1 O PHE B 140 N ILE B 128 SHEET 1 AB2 4 VAL B 241 ASP B 250 0 SHEET 2 AB2 4 PHE B 230 ASP B 238 -1 N LEU B 234 O ALA B 246 SHEET 3 AB2 4 GLU B 217 LEU B 225 -1 N ILE B 220 O LEU B 235 SHEET 4 AB2 4 GLU B 358 VAL B 362 1 O VAL B 360 N PHE B 223 SHEET 1 AB3 2 GLN B 304 TYR B 313 0 SHEET 2 AB3 2 GLU B 316 THR B 323 -1 O GLU B 320 N ILE B 307 SITE 1 AC1 14 TYR A 39 GLY A 255 GLU A 256 GLU A 293 SITE 2 AC1 14 LYS A 296 ARG A 297 SER A 300 GLY A 364 SITE 3 AC1 14 SER A 365 ARG A 367 ILE A 368 HOH A 617 SITE 4 AC1 14 HOH A 731 HOH A 774 SITE 1 AC2 14 TYR B 39 GLY B 227 GLY B 255 GLU B 293 SITE 2 AC2 14 LYS B 296 ARG B 297 SER B 300 GLY B 364 SITE 3 AC2 14 SER B 365 ARG B 367 ILE B 368 HOH B 646 SITE 4 AC2 14 HOH B 678 HOH B 693 CRYST1 55.662 74.775 89.485 90.00 99.48 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017966 0.000000 0.003000 0.00000 SCALE2 0.000000 0.013373 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011330 0.00000